Last reviewed · How we verify
NCT05991167
EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")
trial testing EndeavorRx in ADHD in 150 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2025
Quick facts
| Lead sponsor | Akili Interactive Labs, Inc. |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 June 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- EndeavorRx
Conditions studied
- ADHD — all drugs for ADHD →
Sponsor
Akili Interactive Labs, Inc.
Who can join
Eligibility, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The EndeavorRx Prospective Product Registry aims to collect real world data from participants receiving the digital therapeutic, EndeavorRx, under conditions of routine clinical practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05991167
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of EndeavorRx
Trials testing the same drug.
- NCT05528939 — Feasibility/Acceptability of Attentional-Control Training in Survivors · NA · recruiting
Other recruiting trials for ADHD
Currently open trials in the same condition.
- NCT07314333 — A Trial to Assess How Centanafadine Interacts With Stimulants in the Body · Phase 1 · recruiting
- NCT07262853 — Dual Executive Function Training Package · NA · recruiting
- NCT07291453 — Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits · NA · recruiting
- NCT07281092 — Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) · NA · recruiting
- NCT07219810 — Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD · NA · recruiting
Other Akili Interactive Labs, Inc. trials
Trials by the same sponsor.
- NCT06376032 — EndeavorOTC® Research Study in College Students · NA · active not recruiting
- NCT06109051 — EndeavorOTC™ Prospective Product Registry · active not recruiting
- NCT05183919 — Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult) · NA · completed
- NCT04897074 — Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents) · NA · completed
- NCT03844269 — Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05991167 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Akili Interactive Labs, Inc.
- Last refreshed: 27 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05991167.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing